New Dimensions in Microwave Synthesis
Anton Paar?s Masterwave Benchtop Reactor employs a revolutionary technique for efficient microwave heating of a sealed 1L reaction vessel.
New Dimensions in Microwave Synthesis
Anton Paar’s Masterwave Benchtop Reactor employs a revolutionary technique for efficient microwave heating of a sealed 1L reaction vessel.
With 1700 W microwave output power up to 750 mL operation volume can be processed at 250 °C and 30 bar covering the vast majority of yet developed microwave reactions. An integrated cooling circuit ensures rapid cooling for short overall reaction cycles.
A built-in agitator provides effective stirring for individual contents to improve productivity.
Accurate temperature measurement is accomplished by an internal temperature sensor. This is essential for direct methods transfer from the R&D scale to kilolab production.
The compact batch-type setup fits in any standard fume hood and allows processing of heterogeneous mixtures, highly viscous content, and slurries. Therefore, the reactor can be applied both in the pharmaceutical industry to produce APIs and in material science for the preparation of nanomaterials, functional polymers and lubricants.
Anton Paar GmbH
Website:www.anton-paar.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
